SynDRA canonical compound SYN0001911 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | DHFR |
| Mechanism of action | Dihydrofolate reductase inhibitor |
| Indication | acute lymphoblastic leukemia (ALL) | gestational choriocarcinoma | hydatidiform mole | psoriasis | rheumatoid arthritis |
| Disease area | dermatology | hematologic malignancy | oncology | rheumatology |